» Articles » PMID: 12358764

Distinct Responses of Basal Ganglia Substance P Systems to Low and High Doses of Methamphetamine

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2002 Oct 3
PMID 12358764
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Substance P (SP) is a neuropeptide closely associated with basal ganglia dopaminergic neurons. Because some neuropeptide systems in the basal ganglia (i.e. neurotensin and metenkephalin) are differentially affected by treatment with low or high doses of methamphetamine, we determined if basal ganglia SP pathways were also differentially influenced in a dose-dependent manner by this psychostimulant. Employing in vivo microdialysis, it was observed that the low dose (0.5 mg/kg) of methamphetamine increased the extracellular concentration of SP in the substantia nigra, but not in globus pallidus or striatum. In contrast, the high dose (10 mg/kg) of methamphetamine did not increase extracellular SP content in any of these structures. The effect of the low-dose methamphetamine treatment on nigral extracellular SP levels was blocked by pre-treatment with either a D1 or D2 antagonist. In addition, 12 h after similar methamphetamine treatments, a dose-dependent differential response in SP tissue levels occurred in some of the regions examined. When these changes occurred, the low dose of methamphetamine usually reduced, whereas the high dose increased, SP tissue content. This study demonstrated opposite responses of the basal ganglia SP system to low and high doses of methamphetamine and suggested that a combination of dopamine D1 and D2 receptor activity contributed to these effects.

Citing Articles

Reducing adsorption to improve recovery and in vivo detection of neuropeptides by microdialysis with LC-MS.

Zhou Y, Wong J, Mabrouk O, Kennedy R Anal Chem. 2015; 87(19):9802-9.

PMID: 26351736 PMC: 5118035. DOI: 10.1021/acs.analchem.5b02086.


Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Steiner H, Van Waes V Prog Neurobiol. 2012; 100:60-80.

PMID: 23085425 PMC: 3525776. DOI: 10.1016/j.pneurobio.2012.10.001.


Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.

Cadet J, Jayanthi S, McCoy M, Beauvais G, Cai N CNS Neurol Disord Drug Targets. 2010; 9(5):526-38.

PMID: 20632973 PMC: 3803153. DOI: 10.2174/187152710793361496.


Pharmacotherapy of methamphetamine addiction: an update.

Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J Subst Abus. 2008; 29(3):31-49.

PMID: 19042205 PMC: 2597382. DOI: 10.1080/08897070802218554.


A local circuit model of learned striatal and dopamine cell responses under probabilistic schedules of reward.

Tan C, Bullock D J Neurosci. 2008; 28(40):10062-74.

PMID: 18829964 PMC: 6671259. DOI: 10.1523/JNEUROSCI.0259-08.2008.